Cymabay Therapeutics
Latest round
- Series D
Last raised
- Apr 2007
Total raised
- $86M
Investors
- 16
About Cymabay Therapeutics
Cymabay Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for liver and metabolic disease.Founded in 1991 and headquartered in Newark, US, Cymabay Therapeutics, Inc. specializes in developing treatments for liver and metabolic diseases.00 mn.Cymabay Therapeutics focuses on developing innovative therapeutics for liver diseases. Its offerings include various clinical-stage candidates aimed at addressing unmet needs in metabolic disorders.In 2018, Cymabay Therapeutics recorded a revenue of USD 0, with an EBITDA of USD -92,401,000 for the same year. The company aims to launch new products targeting liver and metabolic diseases, with specific timelines for clinical trial phases yet to be disclosed. Additionally, Cymabay is exploring opportunities for expansion into new markets, although specific geographic regions have not been identified in the current strategy.
Who invested in Cymabay Therapeutics
16 investors across 3 rounds
See all investors in Cymabay Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cymabay Therapeutics
Who invested in Cymabay Therapeutics?
Cymabay Therapeutics has 16 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cymabay Therapeutics raised?
Cymabay Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cymabay Therapeutics last raise money?
Cymabay Therapeutics's most recent round on record is a Series D, in Apr 2007.
What does Cymabay Therapeutics do?
Cymabay Therapeutics is a pharmaceuticals company.
Where is Cymabay Therapeutics headquartered?
Cymabay Therapeutics is headquartered in Newark, US.
Which VCs invest in companies like Cymabay Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Cymabay Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Cymabay Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.